Spinal Clear Cell Meningiomas: Clinical Features and Factors Predicting Recurrence.
As World Health Organization (WHO) grade II tumor in nervous system, clear cell meningioma (CCM) is an uncommon histological variant of meningioma. Spinal CCMs are even rarer, with only less than 100 spinal CCMs reported in the English literature. We present this study to characterize clinical manifestations of spinal CCMs and determine the factors predicting recurrence. A literature search was performed for relevant case reports and series at PubMed and Embase until September 1, 2019. These articles were reviewed to identify clinical features, treatment modalities, and prognosis of patients with spinal CCMs. Eighty-four spinal CCMs were analyzed. Of these cases, 36 (42.9%) were young patients (age ≤18 years), and the mean age at resection was 24 years. Fifty-three (63.1%) patients were female, 31 (36.9%) were male. The majority (56/84, 66.7%) of the tumors were located in the lumbar region. Thirty-one patients (36.9%) involved more than 2 segments in the craniocaudal direction (number of involved segment ≥3 levels). Gross tumor resection (GTR) was performed in 76 (90.5%) patients. Twenty (23.8%) patients showed radiographic evidence of recurrence during the follow-up time. RFS rate at 1- , 5-, and 10-year after resection of spinal CCM was 87%, 71% and 47%, respectively. Multivariate analysis showed that age ≤18 years (hazard ratio [HR], 3.64; p=0.024), subtotal resection (STR) (HR, 3.43; p=0.031) and segments involved ≥3 levels (HR, 5.66; p=0.002) were associated with increased recurrence. Spinal CCMs have their own unique clinical features compared to the conventional spinal meningiomas and intracranial CCMs. Spinal CCMs have a predilection to affect younger patients, are prone to appear in the lumbar region, and has high recurrence rate. Age ≤18 years, STR, and long-segments involved (≥3 levels) are positive predictors of recurrence.